Liver Histological Patterns among HIV-Infected Individuals and Associated Factors of Fibrosis in Northwestern Tanzania: Is There a Role for Non-Invasive Tests?
Background: There is a paucity of data on HIV related liver pathologies and fibrosis in Tanzania, a lower middle income country, where there is a high burden of HIV and empirical treatment is the norm due to lack of investigative and management guidelines. This study aimed to determine the liver histological patterns among HIV-infected individuals and associated factors of fibrosis, as well as the role of non-invasive tests in the detection of fibrosis. Patients and Methods: This was an analytical cross-sectional hospital-based study carried out in Mwanza, Tanzania. HIV-infected individuals with suspected but indeterminate liver disease underwent ultrasound guided liver biopsy to determine histological patterns. Non-invasive tests, APRI and FIB-4, were com-pared with ultrasound-guided liver biopsy in the detection of fibrosis. Logistic regression analyses were performed to assess the association between outcome and exposure variables with a p-value < 0.05 considered statistically significant. Receiver operating characteristic curve analyses were used to compare APRI and FIB-4 performance against ultrasound-guided liver biopsy for the detection of liver fibrosis. Results: A total of 86 participants underwent an ultrasound-guided biopsy and specimen for histopathology. Around 98% of the study participants had histological abnormalities. There was underlying fibrosis in 54.7% of the participants with the second most common histological pattern being chronic hepatitis (48.9%). Other patterns included malignancy (24.4%) with the majority having hepatocellular carcinoma (HCC). Steatosis or steatohepatitis was present in 17.4%. Granulomatous inflammation was seen in 13.9% with the majority being tuberculous in origin. APRI and FIB-4 reported a lower proportion of fibrosis compared to histology. Advanced age (OR = 4.78, 95% CI =1.64 - 13.91), presence of jaundice (OR = 3.59, 95% CI = 1.27 - 10.16) or hepatomegaly (OR = 3.56, 95% CI = 1.25 - 10.16) were independent predictors of fibrosis. On receiver operating characteristic analyses, FIB-4 performed marginally better than APRI in detecting fibrosis in comparison to histology (AUC = 0.56, 95% CI = 0.46 - 0.67 vs. AUC = 0.51, 95% CI = 0.39 - 0.61). Conclusions and Recommendation: Fibrosis is the most prevalent histological pattern among HIV-infected individuals. FIB-4 performed better than APRI as a non-invasive test for detecting fibrosis in comparison to histology. We recommend non-invasive tests for screening underlying fibrosis in HIV-infected individuals.
Cite this paper
Maseke, R. , Manyiri, P. , Majinge, D. , Kidola, J. , Rambau, P. , Kalluvya, S. and Ngoya, P. S. (2025). Liver Histological Patterns among HIV-Infected Individuals and Associated Factors of Fibrosis in Northwestern Tanzania: Is There a Role for Non-Invasive Tests?. Open Access Library Journal, 12, e3760. doi: http://dx.doi.org/10.4236/oalib.1113760.
Sherman, K.E., Rockstroh, J. and Thomas, D. (2015) Hu-man Immunodeficiency Virus and Liver Disease: An Update. Hepatology, 62, 1871-1882. https://doi.org/10.1002/hep.28150
Berzigotti, A., Tsochatzis, E., Boursier, J., Castera, L., Cazzagon, N., Friedrich-Rust, M., et al. (2021) EASL Clinical Practice Guidelines on Non-Invasive Tests for Evaluation of Liver Disease Severity and Prognosis—2021 Up-date. Journal of Hepatology, 75, 659-689. https://doi.org/10.1016/j.jhep.2021.05.025
Lin, K.W., Kumar, R., Shen, F., Chan, H.L., Wong, G.L., Kumar, R., et al. (2023) The Utility of Non-Invasive Tests to Assess Advanced Fibrosis in Asian Subjects with Chronic Hepatitis B and Concomitant Hepatic Steatosis. Liver International, 43, 1008-1014. https://doi.org/10.1111/liv.15541
Hoffmann, C.J., Hoffmann, J.D., Kensler, C., van der Watt, M., Omar, T., Chaisson, R.E., et al. (2015) Tuberculosis and Hepatic Steatosis Are Prevalent Liver Pathology Findings among HIV-Infected Patients in South Africa. PLOS ONE, 10, e0117813. https://doi.org/10.1371/journal.pone.0117813
Wai, C., Greenson, J.K., Fontana, R.J., Kalbfleisch, J.D., Marrero, J.A., Conjeevaram, H.S., et al. (2003) A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients with Chronic Hepatitis C. Hepatology, 38, 518-526. https://doi.org/10.1053/jhep.2003.50346
Vallet-Pichard, A., Mallet, V., Nalpas, B., Verkarre, V., Nalpas, A., Dhalluin-Venier, V., et al. (2007) FIB-4: An Inexpensive and Accurate Marker of Fibrosis in HCV Infection. Comparison with Liver Biopsy and Fibrotest. Hepatology, 46, 32-36. https://doi.org/10.1002/hep.21669
Platt, L., French, C.E., McGowan, C.R., Sabin, K., Gower, E., Trickey, A., et al. (2019) Prev-alence and Burden of HBV Co-Infection among People Living with HIV: A Global Systematic Review and Meta-Analysis. Journal of Viral Hepatitis, 27, 294-315. https://doi.org/10.1111/jvh.13217
Xu, M., Warner, C., Duan, X., Cheng, Z., Jeyarajan, A.J., Li, W., et al. (2024) HIV Coinfection Exacerbates HBV-Induced Liver Fibrogenesis through a HIF-1α- and TGF-β1-Dependent Pathway. Journal of Hepatology, 80, 868-881. https://doi.org/10.1016/j.jhep.2024.01.026
Surial, B., Wyser, D., Béguelin, C., Ramírez‐Mena, A., Rauch, A. and Wandeler, G. (2020) Prevalence of Liver Cirrhosis in Individuals with Hepatitis B Virus Infection in Sub-Saharan Afri-ca: Systematic Review and Meta-Analysis. Liver International, 41, 710-719. https://doi.org/10.1111/liv.14744
Maponga, T.G., Glashoff, R.H., Vermeulen, H., Robertson, B., Burmeister, S., Bernon, M., et al. (2020) Hepatitis B Virus-Associated Hepatocellular Carcinoma in South Africa in the Era of HIV. BMC Gastroenterology, 20, Article No. 226. https://doi.org/10.1186/s12876-020-01372-2
Otedo, A., Simbiri, K.O., Were, V., Ongati, O. and Estambale, B.A. (2018) Risk Factors for Liver Cancer in HIV Endemic Areas of Western Kenya. Infectious Agents and Cancer, 13, Article No. 41. https://doi.org/10.1186/s13027-018-0214-5
Maurice, J.B., Patel, A., Scott, A.J., Patel, K., Thursz, M. and Lemoine, M. (2017) Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in HIV-Monoinfection. AIDS, 31, 1621-1632. https://doi.org/10.1097/qad.0000000000001504
Malindisa, E., Balandya, E., Njelekela, M., Kidenya, B.R., Francis, F., Mmbaga, B.T., et al. (2023) Metabolic Syndrome among People Living with HIV on Antiretroviral Therapy in Mwanza, Tanzania. BMC Endo-crine Disorders, 23, Article No. 88. https://doi.org/10.1186/s12902-023-01340-3
Sonderup, M.W., Wainwright, H., Hall, P., Hairwadzi, H. and Spearman, C.W.N. (2015) A Clinicopathological Cohort Study of Liver Pathology in 301 Patients with Human Im-munodeficiency Virus/acquired Immune Deficiency Syndrome. Hepatology, 61, 1721-1729. https://doi.org/10.1002/hep.27710
Pereira, G.H., Yamagutti, D.C.C. and Mendonça, J.S.D. (2010) Evaluation of the Histopatho-logical Hepatic Lesions and Opportunistic Agents in Brazilian HIV Patients. Revista da Sociedade Brasileira de Medicina Tropical, 43, 1-3. https://doi.org/10.1590/s0037-86822010000100001
Gür-Altunay, D. and Yürük-Atasoy, P. (2023) How Successful Are APRI and FIB-4 Scores in Predicting Liver Fibrosis in Chronic Hepatitis B Patients? Infectious Diseases and Clinical Microbiology, 5, 332-340. https://doi.org/10.36519/idcm.2023.276
Debes, J.D., Bohjanen, P.R. and Boonstra, A. (2016) Mechanisms of Acceler-ated Liver Fibrosis Progression during HIV Infection. Journal of Clinical and Translational Hepatology, 4, 328-335. https://doi.org/10.14218/JCTH.2016.00034